Syndevrx Inc is categorized under Noncommercial Biotechnical Research in Cambridge, MA and active since 2007.
Syndevrx Inc was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Bradley Carver, President at the company’s single location by writing to 1 Broadway Floor 14, Cambridge, Massachusetts MA 02142 or by phoning (617) 401-3110. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Syndevrx Inc |
| Contact Person: | Bradley Carver, President |
| Address: | 1 Broadway Floor 14, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 401-3110 |
| Website Address: | syndevrx.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 9999900 |
| Share This Business: |
Syndevrx Inc was started in 2007 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Bradley Carver, President for inquiries that concern Syndevrx Inc by calling the company number (617) 401-3110, as your correspondence is most welcome. Additionally, the physical location of the single location of Syndevrx Inc can be found at the coordinates 42.362035,-71.082517 as well as the street address 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Syndevrx Inc’s website at syndevrx.com and engage with its social media outlets through on Twitter and on Facebook.